ANIP ANI Pharmaceuticals
- 57.670
- +1.660+2.96%
ANI Pharmaceuticals News
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cook Meredith
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cook Meredith
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Davis Krista
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lalwani Nikhil
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cook Meredith
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shanmugam Muthusamy
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cook Meredith
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shanmugam Muthusamy
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cook Meredith
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gassert Chad
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shanmugam Muthusamy
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shanmugam Muthusamy
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cook Meredith
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marken James G.
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gutwerg Ori
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer CAREY STEPHEN P.
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gassert Chad
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Walsh Patrick D
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Thoma Jeanne
ANI Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director TANNENBAUM RENEE P
Analysis
Price Target
No Data
No Data